• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thalidomide maintenance in multiple myeloma: certainties and controversies.

作者信息

Cavo Michele, Pantani Lucia, Tacchetti Paola, Pallotti Maria Caterina, Brioli Annamaria, Petrucci Alessandro, Zamagni Elena, Tosi Patrizia

出版信息

J Clin Oncol. 2009 Nov 10;27(32):e186-7; author reply e188. doi: 10.1200/JCO.2009.24.0150. Epub 2009 Sep 21.

DOI:10.1200/JCO.2009.24.0150
PMID:19770366
Abstract
摘要

相似文献

1
Thalidomide maintenance in multiple myeloma: certainties and controversies.沙利度胺在多发性骨髓瘤中的维持治疗：肯定之处与争议
J Clin Oncol. 2009 Nov 10;27(32):e186-7; author reply e188. doi: 10.1200/JCO.2009.24.0150. Epub 2009 Sep 21.
2
Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.低剂量沙利度胺与泼尼松龙的巩固治疗可延长接受单次自体干细胞移植手术的多发性骨髓瘤患者的生存期。
J Clin Oncol. 2009 Apr 10;27(11):1788-93. doi: 10.1200/JCO.2008.18.8573. Epub 2009 Mar 9.
3
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.骨髓瘤诱导治疗的移植后结局：沙利度胺与地塞米松对比多柔比星、长春新碱及地塞米松用于高剂量美法仑联合自体干细胞支持治疗之前
Am J Hematol. 2007 Dec;82(12):1071-5. doi: 10.1002/ajh.21038.
4
[Hematopoietic stem cell transplantation for multiple myeloma].[多发性骨髓瘤的造血干细胞移植]
Rinsho Ketsueki. 2009 Oct;50(10):1420-6.
5
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant.
Clin Cancer Res. 2004 Dec 15;10(24):8170-6. doi: 10.1158/1078-0432.CCR-04-1106.
6
Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.自体干细胞移植或传统化疗后难治性或复发性多发性骨髓瘤联合使用苯达莫司汀、泼尼松龙和沙利度胺：一项I期临床试验的结果
Br J Haematol. 2008 Oct;143(2):191-200. doi: 10.1111/j.1365-2141.2008.07076.x. Epub 2008 Aug 24.
7
Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
Nat Clin Pract Oncol. 2008 Feb;5(2):70-1. doi: 10.1038/ncponc1005. Epub 2007 Nov 6.
8
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.与多发性骨髓瘤的双自体移植相比，短期使用沙利度胺联合双自体干细胞移植可改善治疗效果。
J Clin Oncol. 2009 Oct 20;27(30):5001-7. doi: 10.1200/JCO.2009.22.7389. Epub 2009 Aug 31.
9
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.沙利度胺维持治疗可改善多发性骨髓瘤自体造血祖细胞移植后的总生存期。
Cancer. 2006 May 15;106(10):2171-80. doi: 10.1002/cncr.21852.
10
Treatment of multiple myeloma in the targeted therapy era.靶向治疗时代的多发性骨髓瘤治疗
Ann Pharmacother. 2009 Feb;43(2):329-38. doi: 10.1345/aph.1L428. Epub 2009 Feb 3.

引用本文的文献

1
Secondary primary malignancies in multiple myeloma: an old NEMESIS revisited.多发性骨髓瘤中的继发性原发性恶性肿瘤：重温古老的难题
Adv Hematol. 2012;2012:801495. doi: 10.1155/2012/801495. Epub 2012 Jul 19.
2
European perspective on multiple myeloma treatment strategies: update following recent congresses.欧洲视角下的多发性骨髓瘤治疗策略：近期会议后的更新。
Oncologist. 2012;17(5):592-606. doi: 10.1634/theoncologist.2011-0391. Epub 2012 May 9.
3
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
国际骨髓瘤工作组共识方法治疗适合自体干细胞移植的多发性骨髓瘤患者。
Blood. 2011 Jun 9;117(23):6063-73. doi: 10.1182/blood-2011-02-297325. Epub 2011 Mar 29.
4
Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II Study.干扰素-α/粒细胞-巨噬细胞集落刺激因子联合作为自体造血干细胞移植（ASCT）后多发性骨髓瘤患者的维持治疗：一项前瞻性 II 期研究。
Clin Med Insights Oncol. 2010 Nov 16;4:117-25. doi: 10.4137/CMO.S6161.
5
Current multiple myeloma treatment strategies with novel agents: a European perspective.现行多发性骨髓瘤的新型药物治疗策略：欧洲视角。
Oncologist. 2010;15(1):6-25. doi: 10.1634/theoncologist.2009-0203. Epub 2010 Jan 19.